UBS Reiterates Buy Rating on CME Group (CME)

June 5, 2024 4:51 AM UTC Send to a Friend
UBS analyst Alex Kromm reiterated a Buy rating and $250.00 price target on CME Group (NASDAQ: CME).The analyst comments "Following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login